The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

In this month’s issue, the Sexpert advises readers on how to navigate discussions of PrEP and sexual health while in the ...

Senator Sherwin Gatchalian sought the active involvement of parents and local government units (LGUs) to curb the cases of ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

A health advocate here who has tested positive for human immunodeficiency virus (HIV) thanked the World Health Organization (WHO) for ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

The shutdown of HHS web pages pertaining to HIV, LGBTQ+ health, and adolescent health raises questions about the future of infectious disease monitoring and research on these topics.

Researchers at the Duke Human Vaccine Institute are one step closer to creating a vaccine for HIV, or human immunodeficiency virus, which can lead to AIDS (acquired immunodeficiency syndrome).

Health analysts say that the pause in funding for international and domestic efforts to halt HIV and AIDS are "unprecedented.